unfractionated heparin
4 clinical trials
2 abstracts
5 indications
Indication
Respiratory FailureIndication
COVID-19Indication
ApheresisIndication
Anticoagulant therapyAbstract
Non-bacterial thrombotic endocarditis and pancreatic cancer: A literature review.Org: University Tennessee Health Science Center, Hempstead, NY,
Clinical trial
Safety and Efficacy of Argatroban Applicated in Anticoagulation of V-V ECMO: A Randomized Controlled StudyStatus: Completed, Estimated PCD: 2023-12-31
Clinical trial
Efficacy and Safety of Bivalirudin Versus Heparin in Anticoagulant Therapy of ECMO: a Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Randomised, Placebo-controlled Trial to Investigate the Efficacy of Intranasal Heparin Treatment to Reduce Transmission of SARS-CoV-2 Infection and COVID 19 Disease Among Household Contacts of SARS-CoV-2+ Adults and ChildrenStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin AnticoagulationStatus: Completed, Estimated PCD: 2022-12-30
Abstract
Anticoagulation for portal vein thrombosis in patients with hepatocellular carcinoma: A retrospective observational study.Org: Trinity Health of New England, Corewell Health System - Beaumont University Hospital, William Beaumont University Hospital,